Skip to main content

22nd Century Group, Inc.

corporate_fare Company Profile

22nd Century Group, Inc.

XXII·NASDAQ·Manufacturing·CIK 0001347858

22nd Century Group, Inc. is a tobacco products company focused on allowing cigarette smokers to control their nicotine consumption. The company manufactures and distributes combustible tobacco products with minimally or non-addictive nicotine levels, which are authorized by the US Food and Drug Administration (FDA) for retail sale. They also offer contract manufacturing services for cigarettes and filtered cigars to other tobacco brands. Their primary product, the VLN® cigarette, contains 95% less nicotine than traditional cigarettes and is designed to help reduce nicotine consumption. The company aims to provide adult smokers with the option to avoid addictive levels of nicotine. In December 2021, 22nd Century Group received Modified Risk Tobacco Product (MRTP) orders from the FDA for the marketing and sale of their RNC cigarettes, marking the first and only such orders for a combusted tobacco product.

22nd Century Group, Inc. (NASDAQ:XXII) is a publicly traded company in the Manufacturing sector. Wiseek monitors XXII SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • 22nd Century Group Secures $9.5M Non-Dilutive Settlement, Becomes Debt-Free
  • 22nd Century Group Finalizes $20M Highly Dilutive Offering Amid Going Concern Doubts
  • 22nd Century Group Secures Massively Dilutive $20M Preferred Stock and Warrant Offering
  • 22nd Century Group Reports Preliminary FY25 Results; Shareholders Approve Reverse Split & Future Dilution
  • 22nd Century Group Announces 1-for-15 Reverse Stock Split to Regain NASDAQ Compliance

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$17.59M
Net Income
-$5.05M
Diluted EPS
-$52.87
Op. Cash Flow
-$7.72M
Free Cash Flow
-$7.78M
Gross Profit
$7.4M
Operating Income
-$11.57M
Cash & Equivalents
$7.15M
Total Debt
$708K
Debt / Equity
0.04×
Net Margin
-28.7%
Shares Outstanding
510.38K sh
Source: 10-K · filed 2026-03-26 · accession 0001104659-26-034814
$3.6 -0.33% today
52-week range · as of 2026-06-26 $3.85 – $2850
Market cap
$1.36M
Volume
56.9K (1.6× avg)
3-mo avg 35.8K
Live data · 2026-06-27 15:32 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed XXII - Filings & News (Page 2)

XXII
Mar 26, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $3.43
Real-time Price: $3.60 info
Change: +$0.170 (+5%) info
Market Cap: $1.356M info
XXII
Mar 24, 2026, 1:57 PM EDT
Filing Type: 424B5
Importance Score:
10
Price at Filing: $3.45
Real-time Price: $3.60 info
Change: +$0.150 (+4%) info
Market Cap: $1.356M info
XXII
Mar 20, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $3.57
Real-time Price: $3.60 info
Change: +$0.030 (+0.84%) info
Market Cap: $1.356M info
XXII
Feb 20, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.69
Real-time Price: $3.60 info
Change: -$2.09 (-37%) info
Market Cap: $1.356M info
XXII
Jan 22, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.650
Real-time Price: $3.60 info
Change: +$2.95 (+454%) info
Market Cap: $1.356M info